MS news notes: Orelabrutinib, foralumab, diets, coffee and tea
Welcome to “MS News Notes,” a Monday morning column in which I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: A positive report on orelabrutinib Orelabrutinib is one of several experimental Bruton’s tyrosine kinase (BTK)…